| Autor: |
Ginsburg O; Centre for Global Health, US National Cancer Institute, Rockville, MD, USA. Electronic address: Ophira.Ginsburg@nih.gov., Vanderpuye V; Korle Bu Teaching Hospital, Accra, Ghana., Beddoe AM; The Women Global Cancer Initiative, New York, NY, USA., Bhoo-Pathy N; Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia., Bray F; International Agency for Research on Cancer, Lyon, France., Caduff C; Department of Global Health and Social Medicine, King's College London, London, UK., Florez N; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Fadhil I; Eastern Mediterranean NCD Alliance, Kuwait City, Kuwait., Hammad N; Department of Medicine, Division of Hematology-Oncology, St. Michael's Hospital, University of Toronto, Canada; Department of Oncology, Queens University, Kingston, Canada., Heidari S; GENDRO, Geneva, Switzerland; Gender Centre, Geneva Graduate Institute, Geneva, Switzerland., Kataria I; Center for Global Noncommunicable Diseases, RTI International, New Delhi, India., Kumar S; Jhpiego India, Johns Hopkins University Affiliate, Baltimore, MD, USA., Liebermann E; University of Rhode Island College of Nursing, Providence, RI, USA., Moodley J; Cancer Research Initiative, Faculty of Health Sciences, School of Public Health and Family Medicine, and SAMRC Gynaecology Cancer Research Centre, University of Cape Town, Cape Town, South Africa., Mutebi M; Department of Surgery, Aga Khan University, Nairobi, Kenya., Mukherji D; Faculty of Medicine, American University of Beirut, Beirut, Lebanon; Clemenceau Medical Center Dubai, Dubai, United Arab Emirates., Nugent R; Center for Global Noncommunicable Diseases, RTI International, Durham, NC, USA; Department of Global Health, University of Washington, Seattle, WA, USA., So WKW; The Nethersole School of Nursing, Faculty of Medicine, The Chinese University of Hong Kong, New Territories, Hong Kong Special Administrative Region, China., Soto-Perez-de-Celis E; Department of Geriatrics, National Institute of Medical Science and Nutrition Salvador Zubiran, Mexico City, Mexico., Unger-Saldaña K; National Cancer Institute of Mexico, Mexico City, Mexico., Allman G; Center for Global Noncommunicable Diseases, RTI International, Durham, NC, USA., Bhimani J; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bourlon MT; Department of Hemato-Oncology, National Institute of Medical Science and Nutrition Salvador Zubiran, Mexico City, Mexico., Eala MAB; College of Medicine, University of the Philippines, Manila, Philippines; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA., Hovmand PS; Case Western Reserve University, Cleveland, OH, USA., Kong YC; Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia., Menon S; Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, The Capital Region, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark., Taylor CD; Global Focus on Cancer, South Salem, NY, USA., Soerjomataram I; International Agency for Research on Cancer, Lyon, France. |
| Abstrakt: |
Competing Interests: Declaration of interests VV reports leadership or fiduciary roles in other board, society, committee or advocacy groups, paid or unpaid from the American Society of Clinical Oncology, European Society of Medical Oncology, African Organization for Research and Training in Cancer, The Lancet, eCancer, and JCO Global Oncology, and is co-editor of the Translational Oncology journal outside of the submitted work. NB-P reports receiving grants or contracts from Zuellig Pharma, Novartis, Pfizer Malaysia, AIA Sdn Bhd insurance company, and Pharmaceutical Association of Malaysia, outside of the submitted work. NB-P also reports receiving payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Novartis, Pfizer, and Roche; receives support for attending meetings or travel from Roche and the Pharmaceutical Association of Malaysia; reports participating on a Data Safety Monitoring Board or Advisory Board with Pfizer Asia Pacific, Malaysia; reports leadership or a fiduciary role in other board, society, committee, or advocacy groups, paid or unpaid with Together Against Cancer; and reports receipt of equipment, materials, drugs, medical writing, gifts, or other services from Roche Diagnostics, all outside of the submitted work. NF reports receiving consulting fees from Bristol Myers Squibb, Merck, Daiichi Sankyo, Neogenomics, Mirati, and Regeneron; and reports receiving payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from AstraZeneca, Janssen, and Novartis outside of the submitted work. SH reports leadership or a fiduciary role in other board, society, committee, or advocacy groups, paid or unpaid as President of GENDRO, a non-for-profit association that promotes the mainstreaming of gender in academic research and reporting practices. DM reports receiving grants or contracts from Astellas and Pfizer and reports receiving payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Astellas, Janssen, Astra Zeneca, Bayer, Pfizer, Amgen, and Merck Sharp & Dohme outside of the submitted work. DM also reports support for attending meetings or travel from Ipsen, and reports participating on a Data Safety Monitoring Board or Advisory Board with Bayer, Janssen, and Ipsen, all outside of the submitted work. JB reports other financial or non-financial interests with Memorial Sloan Kettering Cancer Center (salaried as full-time postdoctoral research associate, supported internally by the Geoffrey Beene Foundation) outside of the submitted work. PSH reports other financial or non-financial interests with the National Institutes of Health, Center for Global Health (partial salary support through an Intergovernmental Personnel Act Mobility Program) outside of the submitted work. SM reports consulting fees for P-95 (based in Leuven, Belgium) outside of the submitted work. All other authors declare no competing interests. |
